Publications in collaboration with researchers from University of Exeter (25)

2025

  1. A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

    npj Breast Cancer, Vol. 11, Núm. 1

  2. Aspirin, Birthweight, and Large-For-Gestational-Age Neonates: A Secondary Analysis of the ASPRE Trial

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 132, Núm. 11, pp. 1606-1614

  3. Prediction of Small for Gestational Age and Growth-Restricted Neonates at 35 to 36 Weeks of Gestation: A Multicenter Cohort Study

    Medicina (Lithuania), Vol. 61, Núm. 9

  4. Randomized controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trial

    American Journal of Obstetrics and Gynecology MFM, Vol. 7, Núm. 9

  5. Safe and transparent introduction and evaluation of targeted axillary dissection in patients with node-positive breast cancer undergoing primary surgery: International consensus process

    BJS Open, Vol. 9, Núm. 6

2024

  1. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study

    Ultrasound in Obstetrics and Gynecology, Vol. 64, Núm. 1, pp. 57-64

2023

  1. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain

    Ultrasound in Obstetrics and Gynecology, Vol. 62, Núm. 4, pp. 522-530

2022

  1. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35–37 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 1, pp. 69-75

2021

  1. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial

    American Journal of Obstetrics and Gynecology, Vol. 224, Núm. 1, pp. 86.e1-86.e19

  2. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

    Circulation, Vol. 144, Núm. 9, pp. 670-679

  3. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265

2019

  1. Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history

    Ultrasound in Obstetrics and Gynecology, Vol. 54, Núm. 5, pp. 617-624

  2. Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors

    Ultrasound in Obstetrics and Gynecology, Vol. 53, Núm. 5, pp. 649-654

2018

  1. ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm

    Obstetrical and Gynecological Survey, Vol. 73, Núm. 11, pp. 623-625

  2. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm

    Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 6, pp. 738-742

  3. Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Obstetrical and Gynecological Survey

  4. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

    American Journal of Obstetrics and Gynecology, Vol. 218, Núm. 6, pp. 612.e1-612.e6

  5. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 1, pp. 52-59

  6. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 2, pp. 186-195

2017

  1. ASPRE trial: performance of screening for preterm pre-eclampsia

    Ultrasound in Obstetrics and Gynecology, Vol. 50, Núm. 4, pp. 492-495